DUBLIN--(BUSINESS WIRE)--The "Biosensors Market Share, Size, Trends, Industry Analysis Report 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
The global biosensors market size is expected to reach Usd 40.53 billion by 2028
The introduction of nanotechnology-based biosensors, usage of instruments in blood sugar level monitoring in diabetes patients, increasing demand for home-based point-of-care devices due to the COVID-19 pandemic, increasing advancement in technology, and mounting government policies toward diagnostics are some of the significant factors that may complement the global industry development.
Several new technologies have been developed in recent years which will revolutionize biosensor technology. Nano-biosensors have emerged in recent years, and they are increasingly used in various genomics and proteomic techniques
The wide application of the product in the medical field will drive the growth of the industry. It is used in various medical section, including drug discovery, blood gas analyzer, cholesterol checking, infectious diseases, and blood glucose monitoring. Such devices are an essential tool in detecting several conditions, from diabetes to cancer, and thus contribute to industry growth.
There are several developments in the global industry in recent times due to its popularity and increased adoption. Fox BIOSYSTEMS launched a white Fox biosensor in March 2021. The biosensor is developed to overcome clogging in samples such as whole blood or lysates. It can detect microvesicles, nanobodies, antibodies, phage, and small molecules, and the probe in this biosensor is based on generic surface chemistry.
The COVID-19 pandemic is expected to further drive the growth of the global industry during the forecast period owing to the adaptation of the product in COVID-19 diagnosis and monitoring. Various companies are developing new COVID-19 associated products at different development levels, and these products are soon expected to be launched in the industry.
Key players operating in the global market include
- Abbott Laboratories
- Bayer AG
- AZUR Environmental
- Biosensor BV
- DuPont Biosensor Materials
- Cranfield Biotechnology Centre
- Pinnacle Technologies Inc.
- Johnson & Johnson
- Ercon Inc.
- EG & IC Sensors Inc.
- Strategic Diagnostics
- Innovative Biosensors Inc.
- Sysmex Corporation
- LifeScan Inc.
- QTL Biosystems
- Molecular Devices Corp.
- Roche Diagnostics.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
4. Biosensors Market Insights
4.1. Biosensors - Industry snapshot
4.2. Biosensors Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technical advancements in biosensors
4.2.1.2. The rise in acceptance of PoC devices
4.2.2. Restraints and Challenges
4.2.2.1. Limited scalability
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Biosensors Market Industry trends
4.6. COVID-19 Impact Analysis
5. Biosensors Market Assessment by Technology
5.1. Key Findings
5.2. Introduction
5.3. Thermal
5.4. Electrochemical
5.5. Piezoelectric
5.6. Optical
6. Global Biosensors Market, by End-Use
6.1. Key Findings
6.2. Introduction
6.3. Home Healthcare Diagnostics
6.4. PoC Testing
6.5. Food Industry
6.6. Research Laboratories
6.7. Security and Biodefense
7. Biosensors Market Assessment by Application
7.1. Key Findings
7.2. Introduction
7.3. Medical
7.4. Food Toxicity
7.5. Bioreactor
7.6. Agriculture
7.7. Environment
8. Biosensors Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Biosensors Market Assessment, By Geography, 2016 - 2028 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Chapter 9. Company Profiles
10.1. Company Overview
10.2. Financial Performance
10.3. Product Benchmarking
10.4. Recent Development
For more information about this report visit https://www.researchandmarkets.com/r/ev2qvg
